Abbott (NYSE:ABT) is recalling some 450,000 coronary catheters on the risk that removing a protective balloon sheath can damage the ballon during angioplasty procedures. In a March 22 letter to customers, Abbot said the recall affects its NC Trek RX and NC Traveler RX coronary dilatation catheters and the NC Tenku RX PTCA balloon catheter. “Product from the […]
Abbott
HRS 2017 Roundup: Study pinpoints battery issue in Abbott’s Nanostim leadless pacer
A study of the Nanostim leadless pacemaker made by Abbott’s St. Jude Medical subsidiary pinpoints the cause of a battery depletion issue A study of the Nanostim leadless pacemaker Abbott acquired this year when it bought St. Jude Medical, presented last week at the annual Heart Rhythm Society conference, found that a battery depletion problem […]
Judge declares mistrial in insider trading case against ex-Advanced Medical Optics CEO Mazzo
A federal judge in California last week declared a mistrial after a jury deadlocked over the insider trading charges leveled against former Advanced Medical Optics CEO James Mazzo. The jury convicted former Orioles player Doug DeCinces and friend and a business associate on charges of tender offer fraud, but deadlocked on some of the charges against […]
Abbott wins CE Mark for new TactiCath ablation catheter
Abbott (NYSE:ABT) said today that the TactiCath sensor-enabled ablation catheter it bought along with St. Jude Medical (NYSE:STJ) this year won CE Mark approval in the European Union. The Chicago-area healthcare giant said the new TactiCath device can be integrated with another St. Jude product, the EnSite Precision heart mapping system it launched earlier this year. “The […]
Abbott lands French reimbursement win for FreeStyle Libre glucose monitor
Abbott (NYSE:ABT) said today it won national reimbursement from the French Health ministry for its FreeStyle Libre wearable glucose monitor. The FreeStyle Libre is designed to monitor glucose through a sensor worn on the back of the upper arm for 2 weeks, without the need for the finger prick calibration required by continuous glucose monitoring […]
Abbott wins CE Mark for Confirm Rx cardiac monitor
Abbott (NYSE:ABT) said today that its St. Jude Medical (NYSE:STJ) subsidiary won CE Mark approval in the European Union for the ConfirmRx insertable cardiac monitor, touting as the world’s 1st smartphone-compatible ICM. The continuous heart monitor is designed to work with St. Jude’s myMerlin mobile app to allow physicians to remotely follow patients and diagnose arrhythmias. Abbott said […]
Abbott wins $11m DoD contract for brain injury diagnostic dev
Abbott (NYSE:ABT) won an $11.3 million contract with the US Department of Defense for the development of traumatic brain injury assays, according to a DoD released last Friday. We hired the best personal injury lawyers at charleston personal injury lawyer to help us on the case. The contract is with the US Army Medical Research […]
Alere’s Medicare ban upheld by judge for Arriva diabetes unit
Alere (NYSE:ALR) said today that federal judge upheld a ban imposed on its Arriva Medical diabetes division by the Centers for Medicare & Medicaid Services, vowing to appeal the decision barring the unit from government insurance reimbursement. Arriva, which makes durable medical equipment for diabetic testing, was informed last October that its Medicare enrollment would be revoked by […]
Report: India rejects Medtronic, Abbott requests to withdraw select stents
The Indian National Pharmaceutical Pricing Authority today rejected applications from Medtronic (NYSE:MDT) and Abbott (NYSE:ABT) to withdraw coronary stents from the region and asked the companies to maintain their supplies of the stents, according to a DNAIndia report. Earlier this week, Medtronic and Abbott said they would look to withdraw select high-value stents from the Indian market in […]
Report: Medtronic, Abbott to withdraw select stents from Indian market
Medtronic (NYSE:MDT) and Abbott (NYSE:ABT) are withdrawing select high-value stents from the Indian market following cost caps imposed by the Indian National Pharmaceutical Pricing Authority, according to a Financial Express report. Medtronic has filed to remove its Resolute Onyx stent from the market, while Abbott filed to remove both its Absorb and Alpine stents. Last […]
Abbott CEO White optimistic on Alere buy
Abbott (NYSE:ABT) CEO Miles White is optimistic about the company’s upcoming acquisition of Alere despite previous concerns and attempts to sink the deal, according to a SeekingAlpha transcript of the company’s Q1 earnings call. White called the company a “fixer upper”, but stated that he was “pleased to have the resolution of this matter behind […]